Surely the optimum way to perform a trial is to make all the product under the one roof so you can be sure of a uniformity in the entire product. So minimising the chance that there will be variations in that product, which you might possibly get if manufactured in different locations/countries?
Perhaps they need to do a trial using ‘Permatrex’ alone, to see if there is any positive effect in using the ‘vehicle’ on its own, without the drug onboard?
Surely the optimum way to perform a trial is to make all the...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $3.051M | 8.277M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 465836 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 301865 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |